跳至主要内容
临床试验/NCT03375593
NCT03375593Unknown4 期

Narcotic Versus Non-narcotic Medication for Pain Management After Wrist/Hand Fractures: a Randomized Controlled Trial

Lawson Health Research Institute1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2019年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
250
试验地点
1
主要终点
Pain

研究概览

简要总结

The purpose of this study is to evaluate two drug options for pain control in patients following wrist injury. Participants will be randomized to one of the 2 pain relief treatments to determine what treatment provides the most effective pain relief

详细描述

The purposes of this noninferiority randomized clinical trial are to determine whether: 1. the most commonly used non-narcotic analgesic (ibuprofen 600 mg + acetaminophen 500 mg) provides pain relief that is not unacceptably worse than the most commonly prescribed narcotic (hydrocodone 5 mg + acetaminophen 500 mg) in patients with a hand or wrist fracture. 2. the following covariates affect pain outcomes: sex/gender, age, gender-related pain expectations, paid/unpaid work roles, comorbid health status, baseline pain intensity, and employment status.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

study medication will be masked to participant and investigator. Medication will be dispensed by pharmacy in identical blister packs

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients 18 and older undergoing non-operative management of a hand or wrist fracture will be considered eligible.
  • Able to read and speak English

排除标准

  • pain exceeding 7/10 on numeric rating scale or 35/50 on PRWE pain scale at enrollment
  • nerve injury
  • surgeon decision that surgery is required
  • history of chronic opioid use
  • documented or suspected substance abuse
  • individuals currently on daily use of ibuprofen, acetaminophen or other pain-altering medication including medications like Neurontin (gabapentin) and Ultram (tramadol)
  • individuals with documented or suspected chronic pain syndrome, reported allergy or adverse reaction to hydrocodone, acetaminophen, or ibuprofen
  • history or symptoms of serious medical problem in the last year (i.e., arrhythmia, impaired cardiovascular function, gastrointestinal bleeding, liver disease, renal disease)
  • patients with active peptic ulcer disease (history of severe heartburn)
  • symptoms of infection
  • pregnant or lactating women
  • diagnosis of cognitive impairment
  • unable to provide informed consent
  • unable or unwilling to fill out the forms
  • prior fracture in same hand
  • on Coumadin or Plavix
  • other medical or psychological health conditions that preclude them from receiving either intervention
  • or unable to return for follow-up visits

研究组 & 干预措施

Narcotic

Experimental

Hydrocodone 5mg/Acetaminophen 500 mg Tab

干预措施: Acetaminophen 500Mg Tab (Drug)

Narcotic

Experimental

Hydrocodone 5mg/Acetaminophen 500 mg Tab

干预措施: Ibuprofen 600 mg tab (Drug)

Non Narcotic

Experimental

Ibuprofen 600mg Tab + acetaminophen 500 mg Tab

干预措施: Hydrocodone 5Mg/Acetaminophen 500Mg Tab (Drug)

结局指标

主要结局

Pain

时间窗: 0-2 weeks

PRWE (patient rated wrist evaluation) 1. Pain subscale: contains 5 items each of which is further rated from 1-10. The maximum score in this section is 50 and minimum 0 2. Function subscale: contains total 10 items which are further divided into 2 sections i.e specific activities (having 6 items) and usual activities (having 4 items). The maximum score in this section is 50 and minimum 0

次要结局

  • Pain diary(2 weeks)
  • Grip strength(24 weeks)
  • Dexterity(12 and 24 weeks)
  • Adverse events(24 weeks)
  • Drug use(2 weeks)
  • Pinch strength(24 weeks)
  • Range of Motion(12 and 24 weeks)
  • pain management(3 weeks)
  • Work Impact(12 and 24 weeks)
  • Future preference(24 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验